SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001193125-14-305189
Filing Date
2014-08-12
Accepted
2014-08-11 18:13:28
Documents
11
Period of Report
2014-06-30

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q d743226d10q.htm 10-Q 779863
2 EX-31.1 d743226dex311.htm EX-31.1 8316
3 EX-31.2 d743226dex312.htm EX-31.2 8200
4 EX-32.1 d743226dex321.htm EX-32.1 4249
11 GRAPHIC g743226g30c55.jpg GRAPHIC 128462
  Complete submission text file 0001193125-14-305189.txt   4977906

Data Files

Seq Description Document Type Size
5 XBRL INSTANCE DOCUMENT enta-20140630.xml EX-101.INS 671436
6 XBRL TAXONOMY EXTENSION SCHEMA enta-20140630.xsd EX-101.SCH 38053
7 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE enta-20140630_cal.xml EX-101.CAL 62547
8 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE enta-20140630_def.xml EX-101.DEF 130797
9 XBRL TAXONOMY EXTENSION LABEL LINKBASE enta-20140630_lab.xml EX-101.LAB 354584
10 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE enta-20140630_pre.xml EX-101.PRE 248884
Mailing Address 500 ARSENAL STREET WATERTOWN MA 02472
Business Address 500 ARSENAL STREET WATERTOWN MA 02472 617 607 0800
ENANTA PHARMACEUTICALS INC (Filer) CIK: 0001177648 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-35839 | Film No.: 141032075
SIC: 2834 Pharmaceutical Preparations